ZA200610091B - 1-(Indole-6-carbonyl-D-phenylgiycinyl)-4-(1-methylpiperidin-4-yl) piperazine D-tartrate - Google Patents

1-(Indole-6-carbonyl-D-phenylgiycinyl)-4-(1-methylpiperidin-4-yl) piperazine D-tartrate Download PDF

Info

Publication number
ZA200610091B
ZA200610091B ZA200610091A ZA200610091A ZA200610091B ZA 200610091 B ZA200610091 B ZA 200610091B ZA 200610091 A ZA200610091 A ZA 200610091A ZA 200610091 A ZA200610091 A ZA 200610091A ZA 200610091 B ZA200610091 B ZA 200610091B
Authority
ZA
South Africa
Prior art keywords
tartrate
piperazine
carbonyl
indole
phenylglycinyl
Prior art date
Application number
ZA200610091A
Other languages
English (en)
Inventor
Bush Julie Kay
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA200610091B publication Critical patent/ZA200610091B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200610091A 2004-06-30 2006-12-01 1-(Indole-6-carbonyl-D-phenylgiycinyl)-4-(1-methylpiperidin-4-yl) piperazine D-tartrate ZA200610091B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58359904P 2004-06-30 2004-06-30

Publications (1)

Publication Number Publication Date
ZA200610091B true ZA200610091B (en) 2008-02-27

Family

ID=35276192

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200610091A ZA200610091B (en) 2004-06-30 2006-12-01 1-(Indole-6-carbonyl-D-phenylgiycinyl)-4-(1-methylpiperidin-4-yl) piperazine D-tartrate

Country Status (19)

Country Link
US (1) US20070249623A1 (cg-RX-API-DMAC7.html)
EP (1) EP1763521A1 (cg-RX-API-DMAC7.html)
JP (1) JP2008505075A (cg-RX-API-DMAC7.html)
CN (1) CN1984903A (cg-RX-API-DMAC7.html)
AR (1) AR049659A1 (cg-RX-API-DMAC7.html)
AU (1) AU2005267579A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0512245A (cg-RX-API-DMAC7.html)
CA (1) CA2570634A1 (cg-RX-API-DMAC7.html)
EA (1) EA010307B1 (cg-RX-API-DMAC7.html)
EC (1) ECSP067105A (cg-RX-API-DMAC7.html)
IL (1) IL179903A0 (cg-RX-API-DMAC7.html)
MA (1) MA28842B1 (cg-RX-API-DMAC7.html)
MX (1) MXPA06015112A (cg-RX-API-DMAC7.html)
NO (1) NO20070486L (cg-RX-API-DMAC7.html)
PE (1) PE20060480A1 (cg-RX-API-DMAC7.html)
SV (1) SV2006002156A (cg-RX-API-DMAC7.html)
TW (1) TW200603806A (cg-RX-API-DMAC7.html)
WO (1) WO2006011955A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200610091B (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0616574D0 (en) * 2006-08-21 2006-09-27 Glaxo Group Ltd Compounds
CN107365304A (zh) * 2017-08-01 2017-11-21 齐宜涛 一种治疗心血管疾病的化合物及制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (uk) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція
GB9821058D0 (en) * 1998-09-28 1998-11-18 Univ Cardiff Chemical compound
JP2002539194A (ja) * 1999-03-15 2002-11-19 ノボ ノルディスク アクティーゼルスカブ 新規の（２ｒ，３ｒ，４ｒ）−３，４−ジヒドロキシ−２−ヒドロキシメチルピロリジンの塩
WO2000076971A2 (en) * 1999-06-14 2000-12-21 Eli Lilly And Company Serine protease inhibitors
US6448293B1 (en) * 2000-03-31 2002-09-10 Pfizer Inc. Diphenyl ether compounds useful in therapy
GB0030304D0 (en) * 2000-12-13 2001-01-24 Lilly Co Eli Compounds
GB0019228D0 (en) * 2000-08-04 2000-09-27 Smithkline Beecham Plc Novel pharmaceutical
GEP20053712B (en) * 2001-05-14 2005-12-26 Pfizer Prod Inc Tartrate Salts of 5,8,14-Triazatetracyclo {10.3.1.0²,11.04,9}-Hexadeca-2(11),3,5,7,9-Pentaene and Pharmaceutical Compositions Thereof
TWI257389B (en) * 2001-06-12 2006-07-01 Lilly Co Eli Pharmaceutical compound

Also Published As

Publication number Publication date
ECSP067105A (es) 2007-01-26
MA28842B1 (fr) 2007-09-03
CA2570634A1 (en) 2006-02-02
AR049659A1 (es) 2006-08-23
SV2006002156A (es) 2006-02-15
EA200700186A1 (ru) 2007-06-29
MXPA06015112A (es) 2007-02-08
AU2005267579A1 (en) 2006-02-02
BRPI0512245A (pt) 2008-02-19
JP2008505075A (ja) 2008-02-21
IL179903A0 (en) 2007-05-15
TW200603806A (en) 2006-02-01
EA010307B1 (ru) 2008-08-29
NO20070486L (no) 2007-01-25
PE20060480A1 (es) 2006-07-13
CN1984903A (zh) 2007-06-20
US20070249623A1 (en) 2007-10-25
WO2006011955A1 (en) 2006-02-02
EP1763521A1 (en) 2007-03-21

Similar Documents

Publication Publication Date Title
EP1948608B1 (en) Pharmaceutical salts and polymorphs of n-(5-chloro-2-pyridinyl)-2-[[4-[(dimethylamino)iminomethyl]benzoyl]amino]-5-methoxy-benzamide , a factor xa inhibitor
KR20010014165A (ko) 오메프라졸 나트륨염
CN115916780A (zh) (9r,13s)-13-{4-[5-氯-2-(4-氯-1h-1,2,3-三唑-1-基)苯基]-6-氧代-1,6-二氢嘧啶-1-基}-3-(二氟甲基)-9-甲基-3,4,7,15-四氮杂三环[12.3.1.02,6]十八-1(18),2(6),4,14,16-五烯-8-酮的晶型
EP1397348B1 (en) Factor xa inhibitor
US20070249623A1 (en) 1-(Indole-6-Carbonyl-D-Phenylglycinyl)-4-(1-Methylpiperidin-4-Yl)Piperazine D-Tartrate
KR101852226B1 (ko) 오타믹사반의 벤조산염
US20080051388A1 (en) Novel Compounds That Inhibit Factor Xa Activity
CN115463133B (zh) 一种药物组合物、制剂及其制备方法和应用
KR100849242B1 (ko) 1(인돌-6-카르보닐-ｄ-페닐글리시닐)-4-(1-메틸피페리딘-4-일) 피페라진 ｄ-타르트레이트
RU2664538C2 (ru) Тартратная соль [(s)-2-[метил-3-(2-оксо-пирролидин-1-ил)-бензолсульфониламино]-3-(4-метил-пиперазин-1-ил)-3-оксо-пропил]амида 5-хлор-тиофен-2-карбоновой кислоты
CZ20011216A3 (cs) Benzamidové deriváty
US7297706B2 (en) Certain glycine derivatives as factor Xa inhibitors for use in the treatment of thrombotic disorders
EP2805705B1 (en) Packaging with one or more administration units comprising a sodium salt of (R)-3-[6-amino-pyridin-3-yl]-2-(1-cyclohexyl-1 H-imidazol-4-yl)-propionic acid
TW202434612A (zh) 一種二肽類化合物的鹽、其製備方法和用途
HK40082657B (zh) 一种药物组合物、制剂及其制备方法和应用
RU2368610C2 (ru) Кристаллические формы известного пирролидинового ингибитора фактора xa
MX2008005143A (en) Pharmaceutical salts and polymorphs of n- (5-chl0r0-2-pyridinyl) -2- [ [4- [ (dimethylamino) iminomethyl]benzoyl]amino]-5-meth oxy-benzamide, a factor xa inhibitor
NZ620864B2 (en) Crystalline solvates of 6-(piperidin-4-yloxy)-2h-isoquinolin-1-one hydrochloride
NZ620864A (en) Crystalline solvates of 6-(piperidin-4-yloxy)-2h-isoquinolin-1-one hydrochloride
HK1192546B (en) Crystalline solvates of 6-(piperidin-4-yloxy)-2h-isoquinolin-1-one hydrochloride